Borisov Plant of Medical Preparations plans to increase exports to non-CIS states in the near future
Production site of the Borisov Plant of Medical Preparations
At present, the enterprise exports 58 percent of its produce to 24 countries: all the CIS and Baltic States, Georgia, the USA, Macedonia, the Democratic People’s Republic of Korea, Vietnam, Iraq, Egypt, Yemen, Lebanon and Afghanistan, with 40 percent of the goods delivered to Russia.
“Our major principle isn’t to focus exclusively on Russia. We could sell much more to Russia, but we are also trying to work on other markets,” explains Director General of the company, Alexander Fando. According to him, the enterprise is trying to re-orient towards the countries of Asia and Africa.
The plant doesn’t plan to significantly raise exports to the EU in the near future. As Mr. Fando explained, this is connected with high cost of medication registration in Europe which stands at least $500,000, while around $150,000 is spent in Belarus both for registration of the medication and the mastering of its production.
“There’re big doubts that we’ll be able to sell such large amounts of preparations in order to receive back at least our $500,000,” noted Mr. Fando.
Nevertheless, an inspection team has been invited to the factory to receive a European GMP quality certificate and an ampule medication has been chosen for registration in the EU. The company plans to enter the European market through the Baltic States.
